Status:
COMPLETED
Clinical Study on Optimised Removal of Protein-bound Uremic Toxins With Convective Dialysis Treatment.
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
Gambro Corporate Research, Sweden
Conditions:
Chronic Renal Failure
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Patients will be treated with hemodiafiltration (HDF) in postdilution mode, as a control therapy, during 9 weeks. During week 5 the 1st intervention treatment, predilution hemofiltration (HF) or predi...
Eligibility Criteria
Inclusion
- stable on hemodialysis \>= 6 months
- of which presently on high-flux HD \>= 1 month
- 18 years \< age \< 85 years
- blood flow rate \>= 300ml/min
Exclusion
- expected survival \< 1 year
- expected transplant within \< 1 year
- infectious diseases
- pregnancy
- chronic inflammation condition
- treated with single needle dialysis
- presently treated with hemodiafiltration or low-flux hemodiafiltration
- expected intradialytic body weight gain \>= 4kg
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00337831
Start Date
May 1 2006
End Date
May 1 2007
Last Update
June 30 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium, 9000